374 related articles for article (PubMed ID: 31948289)
21. The gut microbiota as a novel regulator of cardiovascular function and disease.
Battson ML; Lee DM; Weir TL; Gentile CL
J Nutr Biochem; 2018 Jun; 56():1-15. PubMed ID: 29427903
[TBL] [Abstract][Full Text] [Related]
22. Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes.
Zhu T; Goodarzi MO
Curr Nutr Rep; 2020 Jun; 9(2):83-93. PubMed ID: 32157661
[TBL] [Abstract][Full Text] [Related]
23. Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease.
Aragonès G; González-García S; Aguilar C; Richart C; Auguet T
Biomed Res Int; 2019; 2019():8507583. PubMed ID: 30719448
[TBL] [Abstract][Full Text] [Related]
24. Gut metagenomic and short chain fatty acids signature in hypertension: a cross-sectional study.
Calderón-Pérez L; Gosalbes MJ; Yuste S; Valls RM; Pedret A; Llauradó E; Jimenez-Hernandez N; Artacho A; Pla-Pagà L; Companys J; Ludwig I; Romero MP; Rubió L; Solà R
Sci Rep; 2020 Apr; 10(1):6436. PubMed ID: 32296109
[TBL] [Abstract][Full Text] [Related]
25. Diet-induced metabolic changes of the human gut microbiome: importance of short-chain fatty acids, methylamines and indoles.
Abdul Rahim MBH; Chilloux J; Martinez-Gili L; Neves AL; Myridakis A; Gooderham N; Dumas ME
Acta Diabetol; 2019 May; 56(5):493-500. PubMed ID: 30903435
[TBL] [Abstract][Full Text] [Related]
26. TMA/TMAO in Hypertension: Novel Horizons and Potential Therapies.
Zhang WQ; Wang YJ; Zhang A; Ding YJ; Zhang XN; Jia QJ; Zhu YP; Li YY; Lv SC; Zhang JP
J Cardiovasc Transl Res; 2021 Dec; 14(6):1117-1124. PubMed ID: 33709384
[TBL] [Abstract][Full Text] [Related]
27. Bacterial Metabolites: A Link between Gut Microbiota and Dermatological Diseases.
Stec A; Sikora M; Maciejewska M; Paralusz-Stec K; Michalska M; Sikorska E; Rudnicka L
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834904
[TBL] [Abstract][Full Text] [Related]
28. Dietary lipids, gut microbiota and lipid metabolism.
Schoeler M; Caesar R
Rev Endocr Metab Disord; 2019 Dec; 20(4):461-472. PubMed ID: 31707624
[TBL] [Abstract][Full Text] [Related]
29. Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease.
Shin Y; Han S; Kwon J; Ju S; Choi TG; Kang I; Kim SS
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892541
[TBL] [Abstract][Full Text] [Related]
30. The Role of the Gut Microbiome and Trimethylamine Oxide in Atherosclerosis and Age-Related Disease.
El Hage R; Al-Arawe N; Hinterseher I
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768722
[TBL] [Abstract][Full Text] [Related]
31. Targeting the human microbiome and its metabolite TMAO in cardiovascular prevention and therapy.
Dannenberg L; Zikeli D; Benkhoff M; Ahlbrecht S; Kelm M; Levkau B; Polzin A
Pharmacol Ther; 2020 Sep; 213():107584. PubMed ID: 32446759
[TBL] [Abstract][Full Text] [Related]
32. Gut Microbiota-Kidney Cross-Talk in Acute Kidney Injury.
Gong J; Noel S; Pluznick JL; Hamad ARA; Rabb H
Semin Nephrol; 2019 Jan; 39(1):107-116. PubMed ID: 30606403
[TBL] [Abstract][Full Text] [Related]
33. The Role of Gut Microbiota and Trimethylamine N-oxide in Cardiovascular Diseases.
Huang Y; Zhang H; Fan X; Wang J; Yin Y; Zhang Y; Shi K; Yu F
J Cardiovasc Transl Res; 2023 Jun; 16(3):581-589. PubMed ID: 36251229
[TBL] [Abstract][Full Text] [Related]
34. Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases.
Sun M; Wu W; Liu Z; Cong Y
J Gastroenterol; 2017 Jan; 52(1):1-8. PubMed ID: 27448578
[TBL] [Abstract][Full Text] [Related]
35. Cranberries attenuate animal-based diet-induced changes in microbiota composition and functionality: a randomized crossover controlled feeding trial.
Rodríguez-Morató J; Matthan NR; Liu J; de la Torre R; Chen CO
J Nutr Biochem; 2018 Dec; 62():76-86. PubMed ID: 30269035
[TBL] [Abstract][Full Text] [Related]
36. Microbial Peer Pressure: The Role of the Gut Microbiota in Hypertension and Its Complications.
Muralitharan RR; Jama HA; Xie L; Peh A; Snelson M; Marques FZ
Hypertension; 2020 Dec; 76(6):1674-1687. PubMed ID: 33012206
[TBL] [Abstract][Full Text] [Related]
37. Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.
Li DY; Tang WHW
Semin Nephrol; 2018 Mar; 38(2):193-205. PubMed ID: 29602401
[TBL] [Abstract][Full Text] [Related]
38. Trimethylamine/Trimethylamine-N-Oxide as a Key Between Diet and Cardiovascular Diseases.
He S; Jiang H; Zhuo C; Jiang W
Cardiovasc Toxicol; 2021 Aug; 21(8):593-604. PubMed ID: 34003426
[TBL] [Abstract][Full Text] [Related]
39. Altered short chain fatty acid profiles induced by dietary fiber intervention regulate AMPK levels and intestinal homeostasis.
Li Q; Chen H; Zhang M; Wu T; Liu R
Food Funct; 2019 Nov; 10(11):7174-7187. PubMed ID: 31602443
[TBL] [Abstract][Full Text] [Related]
40. The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health.
Nogal A; Valdes AM; Menni C
Gut Microbes; 2021; 13(1):1-24. PubMed ID: 33764858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
